Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
暂无分享,去创建一个
Angela Brooks-Wilson | Nathaniel Rothman | Anthony Staines | Stephen J Chanock | Christopher R Flowers | Alexandra Nieters | Qing Lan | Paolo Boffetta | Tongzhang Zheng | Nikolaus Becker | John J Spinelli | Wendy Cozen | Henrik Hjalgrim | Anneclaire J De Roos | Scott Davis | Eleanor Kane | Eve Roman | James R Cerhan | D. Weisenburger | J. Cerhan | C. Flowers | N. Rothman | S. Chanock | P. Hartge | A. Brooks-Wilson | J. Spinelli | C. Skibola | G. Alarcón | S. de Sanjosé | S. Slager | P. Boffetta | L. Forétova | E. Holly | Q. Lan | T. Lightfoot | P. Bracci | Martyn T. Smith | R. Severson | A. Staines | P. Cocco | E. Brown | H. Hjalgrim | O. Martínez-Maza | L. Morton | Sophia S. Wang | S. Davis | N. Becker | O. Paltiel | A. D. De Roos | W. Cozen | B. Birmann | M. Linet | T. Zheng | Yawei Zhang | Y. Benavente | M. Maynadié | E. Roman | K. Smedby | A. Kricker | J. Turner | Susan L Slager | Elizabeth A Holly | Paige M Bracci | Patricia Hartge | Martyn T Smith | Ora Paltiel | Yawei Zhang | A. Nieters | C. Vajdic | Silvia de Sanjose | Tracy Lightfoot | Yolanda Benavente | Lenka Foretova | Marc Maynadie | Anne Kricker | Lindsay M Morton | Richard Severson | Sophia S Wang | Pierluigi Cocco | Martha S Linet | Elizabeth E Brown | Graciela S Alarcón | Christine Skibola | Claire M Vajdic | Brenda M Birmann | Otoniel Martinez-Maza | Jennifer Turner | Karin E Smedby | Elizabeth C Breen | Jenna Voutsinas | Dennis Weisenburger | E. Breen | E. Kane | J. Voutsinas | M. Maynadie | L. Foretova | T. Zheng | E. Brown
[1] R. Rosenquist,et al. Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces? , 2014, Seminars in cancer biology.
[2] K. Humphreys,et al. Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk. , 2013, American journal of human genetics.
[3] S. Chew,et al. Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population , 2013, Nature Genetics.
[4] Paolo Vineis,et al. Genome-wide Association Study Identifies Multiple Risk Loci for Chronic Lymphocytic Leukemia , 2013, Nature Genetics.
[5] M. Shlomchik,et al. Rheumatoid Factor B Cell Memory Leads to Rapid, Switched Antibody-Forming Cell Responses , 2013, The Journal of Immunology.
[6] S. Ing,et al. Follicular helper T cells: new insights into mechanisms of autoimmune diseases. , 2013, The Ochsner journal.
[7] K. Humphreys,et al. A meta-analysis of genome-wide association studies of follicular lymphoma , 2012, BMC Genomics.
[8] Anthony Staines,et al. A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk , 2012, International journal of cancer.
[9] C. Prati,et al. Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: a cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients. , 2012, Joint, bone, spine : revue du rhumatisme.
[10] Avner Schlessinger,et al. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI , 2012 .
[11] J. Cerhan,et al. Variation in Effects of Non-Hodgkin Lymphoma Risk Factors According to the Human Leukocyte Antigen (HLA)-DRB1*01:01 Allele and Ancestral Haplotype 8.1 , 2011, PloS one.
[12] P. Broderick,et al. Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk , 2011, British journal of haematology.
[13] Peter Boyle,et al. GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma , 2011, PLoS genetics.
[14] Robert M. Plenge,et al. Meta-Analysis of Genome-Wide Association Studies in Celiac Disease and Rheumatoid Arthritis Identifies Fourteen Non-HLA Shared Loci , 2011, PLoS genetics.
[15] Alexandra G. Smith,et al. Epidemiology of lymphomas , 2011, Histopathology.
[16] J. Cerhan,et al. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. , 2011, International journal of molecular epidemiology and genetics.
[17] R. Houlston,et al. Genetic variation and risk of chronic lymphocytic leukaemia. , 2010, Seminars in cancer biology.
[18] Adele Seniori Costantini,et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. , 2010, Blood.
[19] E. Campo,et al. Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk , 2010, British journal of haematology.
[20] Kevin M. Brown,et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32 , 2010, Nature Genetics.
[21] J. Cerhan,et al. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. , 2010, Blood.
[22] Y. Shoenfeld,et al. Geo-epidemiology and autoimmunity. , 2010, Journal of autoimmunity.
[23] J. Cerhan,et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. , 2010, American journal of epidemiology.
[24] T. Lash,et al. Validity of self‐reported rheumatoid arthritis in a large cohort: Results from the Black Women's Health Study , 2010, Arthritis care & research.
[25] E. Campo,et al. Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk , 2010, Nature Genetics.
[26] Eran Halperin,et al. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma , 2009, Nature Genetics.
[27] S. Berndt,et al. Population‐based study of autoimmune conditions and the risk of specific lymphoid malignancies , 2009, International journal of cancer.
[28] X. Mariette,et al. Autoimmune and inflammatory disorders and risk of malignant lymphomas – an update , 2008, Journal of internal medicine.
[29] Guy Pratt,et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia , 2008, Nature Genetics.
[30] S. Romagnani. Human Th17 cells , 2008, Arthritis research & therapy.
[31] J. Cerhan,et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. , 2008, Blood.
[32] Robert M. Plenge,et al. Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis , 2008, PLoS genetics.
[33] R. Gascoyne,et al. Organochlorines and risk of non‐Hodgkin lymphoma , 2007, International journal of cancer.
[34] V. Kuchroo,et al. Th17 cells: effector T cells with inflammatory properties. , 2007, Seminars in immunology.
[35] M. Oukka. Interplay between pathogenic Th17 and regulatory T cells , 2007, Annals of the rheumatic diseases.
[36] M. Ramos-Casals,et al. Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors. , 2007, Rheumatology.
[37] D. Weisenburger,et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). , 2007, Blood.
[38] J. Cerhan,et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. , 2007, Cancer research.
[39] M. Weinblatt,et al. Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries. , 2007, Arthritis and rheumatism.
[40] J. Askling,et al. Malignant Lymphomas in Autoimmunity and Inflammation: A Review of Risks, Risk Factors, and Lymphoma Characteristics , 2006, Cancer Epidemiology Biomarkers & Prevention.
[41] Nilanjan Chatterjee,et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. , 2006, Cancer research.
[42] F. Chiarelli,et al. Autoimmunity: Basic Mechanisms and Implications in Endocrine Diseases , 2006, Hormone Research in Paediatrics.
[43] F. Chiarelli,et al. Autoimmunity: Basic Mechanisms and Implications in Endocrine Diseases , 2006, Hormone Research in Paediatrics.
[44] E. Holly,et al. Residential History, Family Characteristics and Non–Hodgkin Lymphoma, A Population-Based Case-Control Study in the San Francisco Bay Area , 2006, Cancer Epidemiology Biomarkers & Prevention.
[45] A. Iliadou,et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[46] H. Adami,et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. , 2006, Journal of the National Cancer Institute.
[47] Theodore R Holford,et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. , 2006, The Lancet. Oncology.
[48] J. Cerhan,et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. , 2005, American journal of epidemiology.
[49] T. Rüdiger,et al. Medical history and risk for lymphoma: results of a population-based case-control study in Germany. , 2005, European journal of cancer.
[50] J. Kaldor,et al. Sun exposure may protect against non‐Hodgkin lymphoma: A case‐control study , 2004, International journal of cancer.
[51] J. Cerhan,et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[52] P. Boyle,et al. Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women , 2004, Cancer Causes & Control.
[53] E. Holly,et al. Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. , 2003, American journal of epidemiology.
[54] G. Cooper,et al. The epidemiology of autoimmune diseases. , 2003, Autoimmunity reviews.
[55] D. Kunz,et al. Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. , 2003, Critical care medicine.
[56] D. Hossfeld. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .
[57] P. Youinou,et al. Recent Progress in the Understanding of B‐Cell Functions in Autoimmunity , 2001, Scandinavian journal of immunology.
[58] O. Nanni,et al. Haematopoietic cancer and medical history: a multicentre case control study , 2000, Journal of epidemiology and community health.
[59] S. Franceschi,et al. Medical history and risk of Hodgkin's and non‐Hodgkin's lymphomas , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[60] H. Mcdevitt,et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.